Live Breaking News & Updates on Hendrik Schulze Koops

Stay updated with breaking news from Hendrik schulze koops. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

'Split' decision: JAK inhibitors have delivered on only part of their promise

Janus kinase inhibitors have delivered on some, but not all, of the promises that were expected of them upon approval in 2012, a speaker said at EULAR 2022 Congress.“I am trying to bring to you arguments for why particular promises associated with JAK inhibition have been fulfilled and why others have not,” Hendrik Schulze-Koops, MD, of the Ludwig Maximilian University of Munich, said ....

Rob Volansky , Schulze Koopsh Jaki , Hendrik Schulze Koops , Gilead Sciences , Boehringer Ingelheim , Biogen International , Eli Lilly Co , Ludwig Maximilian University Of Munich , Eli Lilly , Shire Baxalta , Ludwig Maximilian University ,